Previous close | 8.31 |
Open | 8.24 |
Bid | 8.06 x 200 |
Ask | 8.14 x 300 |
Day's range | 8.09 - 8.35 |
52-week range | 7.53 - 15.70 |
Volume | |
Avg. volume | 4,586,900 |
Market cap | 1.301B |
Beta (5Y monthly) | 0.55 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
OPKO Health (OPK) and Entera Bio announce robust pharmacokinetic results for the proprietary GLP-2 agonist developed by OPK Heath.
Shares of Ironwood Pharmaceuticals collapsed Thursday on mixed results for its gastrointestinal drug. The biotech stock erased a 38% gain.
Ironwood Pharmaceuticals ( NASDAQ:IRWD ) Full Year 2023 Results Key Financial Results Revenue: US$442.7m (up 7.8% from...